The D-Tip Denudation Pipette
Allwin Medical Devices, Inc. · Decision date Oct 9, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for The D-Tip Denudation Pipette, submitted by Allwin Medical Devices, Inc. of Anaheim, California, under 510(k) number K261234. The decision date is 09 October 2026, and the application was received 15 April 2026. The device falls under product code MQH, classified as microtools for assisted reproduction (pipettes), regulation number 884.6130, with a review panel and medical specialty of Obstetrics/Gynecology. The filing is a traditional 510(k), was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan.
Substantially equivalent means FDA cleared the submission for marketing; it is not premarket approval of a new device. The record does not describe the pipette's design, materials, intended clinical use, or the predicate device it was compared against, and no summary statement is present in the supplied data. The RSS listing independently confirms the same decision and applicant on the same date. Any reading of clinical role or comparative performance would require the underlying FDA documents, which are not included here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Oct 9, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261234
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Allwin Medical Devices, Inc.
- Product code
- MQH
- Decision code
- SESE
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Microtools, Assisted Reproduction (Pipettes).
- Applicant
- Allwin Medical Devices, Inc.
- Product code
- MQH
- FDA device class
- 2
FDA decision timeline
K261234 received
Application receipt date recorded by FDA.
K261234 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Allwin Medical Devices, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Anaheim, CA
Sources and methodology
- Original FDA record: K261234
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records